» Articles » PMID: 35606393

Evaluation of Different Types of Face Masks to Limit the Spread of SARS-CoV-2: a Modeling Study

Overview
Journal Sci Rep
Specialty Science
Date 2022 May 23
PMID 35606393
Authors
Affiliations
Soon will be listed here.
Abstract

We expanded a published mathematical model of SARS-CoV-2 transmission with complex, age-structured transmission and with laboratory-derived source and wearer protection efficacy estimates for a variety of face masks to estimate their impact on COVID-19 incidence and related mortality in the United States. The model was also improved to allow realistic age-structured transmission with a pre-specified R0 of transmission, and to include more compartments and parameters, e.g. for groups such as detected and undetected asymptomatic infectious cases who mask up at different rates. When masks are used at typically-observed population rates of 80% for those ≥ 65 years and 60% for those < 65 years, face masks are associated with 69% (cloth) to 78% (medical procedure mask) reductions in cumulative COVID-19 infections and 82% (cloth) to 87% (medical procedure mask) reductions in related deaths over a 6-month timeline in the model, assuming a basic reproductive number of 2.5. If cloth or medical procedure masks' source control and wearer protection efficacies are boosted about 30% each to 84% and 60% by cloth over medical procedure masking, fitters, or braces, the COVID-19 basic reproductive number of 2.5 could be reduced to an effective reproductive number ≤ 1.0, and from 6.0 to 2.3 for a variant of concern similar to delta (B.1.617.2). For variants of concern similar to omicron (B.1.1.529) or the sub-lineage BA.2, modeled reductions in effective reproduction number due to similar high quality, high prevalence mask wearing is more modest (to 3.9 and 5.0 from an R = 10.0 and 13.0, respectively). None-the-less, the ratio of incident risk for masked vs. non-masked populations still shows a benefit of wearing masks even with the higher R0 variants.

Citing Articles

Does the use of protective face masks affect temporomandibular joint function?.

Gorgu S, Yildirim Y, Kaya P, Ergezen G, Uzuner E Pak J Med Sci. 2025; 41(2):432-436.

PMID: 39926658 PMC: 11803774. DOI: 10.12669/pjms.41.2.10588.


High-frequency PCR-testing as a powerful approach for SARS-CoV-2 surveillance in the field of critical infrastructure: A longitudinal, retrospective study in a German tertiary care hospital.

Fischer B, Farr M, Gummert J, Knabbe C, Vollmer T PLoS One. 2025; 20(2):e0317009.

PMID: 39913462 PMC: 11801583. DOI: 10.1371/journal.pone.0317009.


Examination of factors that impact mask or respirator purchase and usage during the COVID-19 pandemic.

Bertges N, Shearman S, Imai S, Balanay J, Sousan S PLoS One. 2024; 19(9):e0308841.

PMID: 39321174 PMC: 11423998. DOI: 10.1371/journal.pone.0308841.


COVID-19: did the masks work?.

Sleator R, Smith N Future Microbiol. 2024; 19(11):997-1002.

PMID: 39109652 PMC: 11318738. DOI: 10.1080/17460913.2024.2343558.


Effect of face masks on dyspnea perception, cardiopulmonary parameters, and facial temperature in healthy adults.

Ramoti N, Siahaan A, Indharty S, Adella C Narra J. 2024; 4(1):e574.

PMID: 38798847 PMC: 11125298. DOI: 10.52225/narra.v4i1.574.


References
1.
Ueki H, Furusawa Y, Iwatsuki-Horimoto K, Imai M, Kabata H, Nishimura H . Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2. mSphere. 2020; 5(5). PMC: 7580955. DOI: 10.1128/mSphere.00637-20. View

2.
Brandal L, MacDonald E, Veneti L, Ravlo T, Lange H, Naseer U . Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021. Euro Surveill. 2021; 26(50). PMC: 8728491. DOI: 10.2807/1560-7917.ES.2021.26.50.2101147. View

3.
Oran D, Topol E . Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review. Ann Intern Med. 2020; 173(5):362-367. PMC: 7281624. DOI: 10.7326/M20-3012. View

4.
Laine C, Goodman S, Guallar E . The Role of Masks in Mitigating the SARS-CoV-2 Pandemic: Another Piece of the Puzzle. Ann Intern Med. 2020; 174(3):419-420. PMC: 7713907. DOI: 10.7326/M20-7448. View

5.
Byambasuren O, Cardona M, Bell K, Clark J, McLaws M, Glasziou P . Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis. J Assoc Med Microbiol Infect Dis Can. 2022; 5(4):223-234. PMC: 9602871. DOI: 10.3138/jammi-2020-0030. View